SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    F. B. S. Briggs, B. S. Acuna, L. Shen, K. H. Bellesis, P. P. Ramsay, H. Quach, A. Bernstein, C. Schaefer, L. F. Barcellos, Adverse socioeconomic position during the life course is associated with multiple sclerosis, Journal of Epidemiology & Community Health, 2014, 68, 7, 622

    CrossRef

  2. 2
    Arndt Manzel, Oliver Domenig, Bjoern Ambrosius, Agnes Kovacs, Johannes Stegbauer, Marko Poglitsch, Dominik N. Mueller, Ralf Gold, Ralf A. Linker, Angiotensin IV is Induced in Experimental Autoimmune Encephalomyelitis but Fails to Influence the Disease, Journal of Neuroimmune Pharmacology, 2014, 9, 4, 533

    CrossRef

  3. 3
    Franziska Hoffmann, Edgar Meinl, B cells in Multiple Sclerosis: Good or bad guys?, European Journal of Immunology, 2014, 44, 5
  4. 4
    U. E. Williams, S. K. Oparah, E. E. Philip-Ephraim, Disease Modifying Therapy in Multiple Sclerosis, International Scholarly Research Notices, 2014, 2014, 1

    CrossRef

  5. 5
    Cem İsmail Küçükali, Murat Kürtüncü, Arzu Çoban, Merve Çebi, Erdem Tüzün, Epigenetics of Multiple Sclerosis: An Updated Review, NeuroMolecular Medicine, 2014,

    CrossRef

  6. 6
    Giuseppe Mameli, Davide Cossu, Eleonora Cocco, Speranza Masala, Jessica Frau, Maria Giovanna Marrosu, Leonardo A. Sechi, Epstein–Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients, Journal of Neuroimmunology, 2014, 270, 1-2, 51

    CrossRef

  7. 7
    Nadia Ben Fredj, Roberta Rizzo, Daria Bortolotti, Faten Nefzi, Saber Chebel, Antonella Rotola, Mahbouba Frih-Ayed, Dario Di Luca, Mahjoub Aouni, Evaluation of the implication of KIR2DL2 receptor in multiple sclerosis and herpesvirus susceptibility, Journal of Neuroimmunology, 2014, 271, 1-2, 30

    CrossRef

  8. 8
    Hatice Nida Sen, Janet Davis, Didar Ucar, Austin Fox, Chi Chao Chan, Debra A. Goldstein, Gender Disparities in Ocular Inflammatory Disorders*, Current Eye Research, 2014, 1

    CrossRef

  9. 9
    Silvia Messina, Francesco Patti, Gray Matters in Multiple Sclerosis: Cognitive Impairment and Structural MRI, Multiple Sclerosis International, 2014, 2014, 1

    CrossRef

  10. 10
    C. Tørring, C. Andreasen, N. Gehr, L. Bjerg, T. Petersen, P. Höllsberg, Higher incidence of Epstein–Barr virus-induced lymphocyte transformation in multiple sclerosis, Acta Neurologica Scandinavica, 2014, 130, 2
  11. 11
    Bibiana Bielekova, Yoram Vodovotz, Gary An, John Hallenbeck, How Implementation of Systems Biology into Clinical Trials Accelerates Understanding of Diseases, Frontiers in Neurology, 2014, 5,

    CrossRef

  12. 12
    Rina Aharoni, Immunomodulation neuroprotection and remyelination – The fundamental therapeutic effects of glatiramer acetate: A critical review, Journal of Autoimmunity, 2014,

    CrossRef

  13. 13
    Adipong Brickshawana, Shannon R Hinson, Michael F Romero, Claudia F Lucchinetti, Yong Guo, Mathias Buttmann, Andrew McKeon, Sean J Pittock, Min-Hwang Chang, An-Ping Chen, Thomas J Kryzer, James P Fryer, Sarah M Jenkins, Philippe Cabre, Vanda A Lennon, Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study, The Lancet Neurology, 2014, 13, 8, 795

    CrossRef

  14. 14
    Karelle Bénardais, Viktoria Gudi, Lijie Gai, Jasmin Neßler, Vikramjeet Singh, Chittappen K. Prajeeth, Thomas Skripuletz, Martin Stangel, Long-term impact of neonatal inflammation on demyelination and remyelination in the central nervous system, Glia, 2014, 62, 10
  15. 15
    Amany A. Abdin, Eiman A. Hasby, Modulatory effect of celastrol on Th1/Th2 cytokines profile, TLR2 and CD3+ T-lymphocyte expression in a relapsing-remitting model of multiple sclerosis in rats, European Journal of Pharmacology, 2014,

    CrossRef

  16. 16
    Eytan Raz, Simona Pontecorvo, Veronica Barra, Beatrice Cavallo Marincola, Manuela Morreale, Emanuele Tinelli, Luca Saba, Pier Luigi Paolo, Alessandro Aceti, Carlo Catalano, Ada Francia, Francesca Caramia, MR Venography in Patients with Multiple Sclerosis and Correlation with Clinical and MRI Parameters, Journal of Neuroimaging, 2014, 24, 5
  17. 17
    Klemens Ruprecht, Benjamin Wunderlich, René Gieß, Petra Meyer, Madlen Loebel, Klaus Lenz, Jörg Hofmann, Berit Rosche, Oliver Wengert, Friedemann Paul, Ulf Reimer, Carmen Scheibenbogen, Multiple sclerosis: The elevated antibody response to Epstein–Barr virus primarily targets, but is not confined to, the glycine–alanine repeat of Epstein–Barr nuclear antigen-1, Journal of Neuroimmunology, 2014, 272, 1-2, 56

    CrossRef

  18. 18
    Sonia Berrih-Aknin, Myasthenia Gravis: Paradox versus paradigm in autoimmunity, Journal of Autoimmunity, 2014, 52, 1

    CrossRef

  19. 19
    Franca R. Guerini, Mario Clerici, Rachele Cagliani, Sunny Malhotra, Xavier Montalban, Diego Forni, Cristina Agliardi, Stefania Riva, Domenico Caputo, Daniela Galimberti, Rosanna Asselta, Chiara Fenoglio, Elio Scarpini, Giacomo P. Comi, Nereo Bresolin, Manuel Comabella, Manuela Sironi, No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis, Journal of Neuroimmunology, 2014, 271, 1-2, 49

    CrossRef

  20. 20
    Klaus Lauer, Notes on the Epidemiology of Multiple Sclerosis, with Special Reference to Dietary Habits, International Journal of Molecular Sciences, 2014, 15, 3, 3533

    CrossRef

  21. 21
    V. Zsiros, Z. Fricska-Nagy, J. Füvesi, Z. T. Kincses, É. Langane, E. Paulik, L. Vécsei, K. Bencsik, Prevalence of multiple sclerosis in Csongrád County, Hungary, Acta Neurologica Scandinavica, 2014, 130, 3
  22. 22
    J. Pakpoor, S. V. Ramagopalan, Russell W Brain and the aetiology of multiple sclerosis--a historical perspective, QJM, 2014, 107, 6, 423

    CrossRef

  23. 23
    Farren B. S. Briggs, Brigid Acuna, Ling Shen, Patricia Ramsay, Hong Quach, Allan Bernstein, Kalliope H. Bellesis, Ingrid S. Kockum, Anna K. Hedström, Lars Alfredsson, Tomas Olsson, Catherine Schaefer, Lisa F. Barcellos, Smoking and Risk of Multiple Sclerosis, Epidemiology, 2014, 25, 4, 605

    CrossRef

  24. 24
    Brett J. Wade, Spatial Analysis of Global Prevalence of Multiple Sclerosis Suggests Need for an Updated Prevalence Scale, Multiple Sclerosis International, 2014, 2014, 1

    CrossRef

  25. 25
    Thad A. Rosenberger, Targeting calpain-mediated proteolysis and peptide signaling as a strategy to reduce injury in multiple sclerosis, Journal of Neurochemistry, 2014, 130, 2
  26. 26
    Elizabeth Visser, Denis Milne, Ian Collacott, David McLernon, Carl Counsell, Mark Vickers, The epidemiology of infectious mononucleosis in Northern Scotland: a decreasing incidence and winter peak, BMC Infectious Diseases, 2014, 14, 1, 151

    CrossRef

  27. 27
    Matilde Inglese, Maria Petracca, Therapeutic strategies in multiple sclerosis: A focus on neuroprotection and repair and relevance to schizophrenia, Schizophrenia Research, 2014,

    CrossRef

  28. 28
    M. L. Greenberg, J. G. Weinger, M. P. Matheu, K. S. Carbajal, I. Parker, W. B. Macklin, T. E. Lane, M. D. Cahalan, Two-photon imaging of remyelination of spinal cord axons by engrafted neural precursor cells in a viral model of multiple sclerosis, Proceedings of the National Academy of Sciences, 2014, 111, 22, E2349

    CrossRef

  29. 29
    Shurong Duan, Zheng Lv, Xiaoxue Fan, Le Wang, Fei Han, Hong Wang, Sheng Bi, Vitamin D status and the risk of multiple sclerosis: A systematic review and meta-analysis, Neuroscience Letters, 2014, 570, 108

    CrossRef

  30. 30
    Douglas S. Goodin, Multiple Sclerosis and Related Disorders, 2014,

    CrossRef

  31. 31
    Veena Taneja, Ashutosh Mangalam, Chella S. David, The Autoimmune Diseases, 2014,

    CrossRef

  32. 32
    Margaret A. Jordan, Judith Field, Helmut Butzkueven, Alan G. Baxter, The Autoimmune Diseases, 2014,

    CrossRef

  33. 33
    J.-J. Sheu, H.-C. Lin, Association between multiple sclerosis and chronic periodontitis: a population-based pilot study, European Journal of Neurology, 2013, 20, 7
  34. 34
    Lekha Pandit, Chaitra Malli, Anita D'Cunha, Rajesh Shetty, Bhim Singhal, Association of Epstein–Barr virus infection with multiple sclerosis in India, Journal of the Neurological Sciences, 2013, 325, 1-2, 86

    CrossRef

  35. 35
    Fanglin Zhang, Song-Yi Yao, William O. Whetsell, Subramaniam Sriram, Astrogliopathy and oligodendrogliopathy are early events in CNS demyelination, Glia, 2013, 61, 8
  36. 36
    M. F. Davis, S. Sriram, W. S. Bush, J. C. Denny, J. L. Haines, Automated extraction of clinical traits of multiple sclerosis in electronic medical records, Journal of the American Medical Informatics Association, 2013, 20, e2, e334

    CrossRef

  37. 37
    Nopporn Jongkamonwiwat, Parinya Noisa, Biomedical and Clinical Promises of Human Pluripotent Stem Cells for Neurological Disorders, BioMed Research International, 2013, 2013, 1

    CrossRef

  38. 38
    Jan Dörr, Andrea Döring, Friedemann Paul, Can we prevent or treat multiple sclerosis by individualised vitamin D supply?, EPMA Journal, 2013, 4, 1, 4

    CrossRef

  39. 39
    Alberto Gajofatto, Massimiliano Calabrese, Maria Donata Benedetti, Salvatore Monaco, Clinical, MRI, and CSF Markers of Disability Progression in Multiple Sclerosis, Disease Markers, 2013, 35, 687

    CrossRef

  40. 40
    Bert A. ‘t Hart, Wilfred F. den Dunnen, Commentary on Special Issue: CNS Diseases and the Immune System, Journal of Neuroimmune Pharmacology, 2013, 8, 4, 757

    CrossRef

  41. 41
    Julia Pakpoor, Jina Pakpoor, Giulio Disanto, Gavin Giovannoni, Sreeram V. Ramagopalan, Cytomegalovirus and multiple sclerosis risk, Journal of Neurology, 2013, 260, 6, 1658

    CrossRef

  42. 42
    Giuseppe Mameli, Davide Cossu, Eleonora Cocco, Speranza Masala, Jessica Frau, Maria Giovanna Marrosu, Leonardo A. Sechi, EBNA-1 IgG titers in Sardinian multiple sclerosis patients and controls, Journal of Neuroimmunology, 2013, 264, 1-2, 120

    CrossRef

  43. 43
    Marcus W. Koch, Luanne M. Metz, Smriti M. Agrawal, V. Wee Yong, Environmental factors and their regulation of immunity in multiple sclerosis, Journal of the Neurological Sciences, 2013, 324, 1-2, 10

    CrossRef

  44. 44
    Alberto Ascherio, Environmental factors in multiple sclerosis, Expert Review of Neurotherapeutics, 2013, 13, 12s, 3

    CrossRef

  45. 45
    Marcus W. Koch, Luanne M. Metz, Olga Kovalchuk, Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis, Trends in Molecular Medicine, 2013, 19, 1, 23

    CrossRef

  46. 46
    Julia Pakpoor, Gavin Giovannoni, Sreeram V Ramagopalan, Epstein–Barr virus and multiple sclerosis: association or causation?, Expert Review of Neurotherapeutics, 2013, 13, 3, 287

    CrossRef

  47. 47
    F. Verheul, J. Smolders, M. Trojano, V. Lepore, C. Zwanikken, M. P. Amato, F. Grand'Maison, H. Butzkueven, M. Marrosu, P. Duquette, G. Comi, G. Izquierdo, P. Grammond, G. Lus, T. Petersen, R. Bergamaschi, G. Giuliani, C. Boz, G. Coniglio, V. Pesch, J. Lechner-Scott, P. Cavalla, F. Granella, C. Avolio, M. Fiol, D. Poehlau, M. L. Saladino, P. Gallo, N. Deri, W. Oleschko Arruda, M. Paine, M. Ferro, M. Barnett, J. A. Cabrera-Gomez, M. Slee, F. Moore, C. Shaw, T. Petkovska-Boskova, M. Rutherford, O. Engelsen, J. Damoiseaux, R. Hupperts, Fluctuations of MS births and UV-light exposure, Acta Neurologica Scandinavica, 2013, 127, 5
  48. 48
    E. Peelen, M. Thewissen, S. Knippenberg, J. Smolders, A.-H. Muris, P. Menheere, J.W. Cohen Tervaert, R. Hupperts, J. Damoiseaux, Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators, Journal of Neuroimmunology, 2013, 258, 1-2, 77

    CrossRef

  49. You have free access to this content49
    Jun-ichi Kira, Genetic and environmental factors underlying the rapid changes in epidemiological and clinical features of multiple sclerosis and neuromyelitis optica in Japanese, Clinical and Experimental Neuroimmunology, 2013, 4, 3
  50. 50
    Dorothea Buck, Eva Albrecht, Muhammad Aslam, An Goris, Natalie Hauenstein, Angela Jochim, Sabine Cepok, Verena Grummel, Bénédicte Dubois, Achim Berthele, Peter Lichtner, Christian Gieger, Juliane Winkelmann, Bernhard Hemmer, Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis, Annals of Neurology, 2013, 73, 1
  51. 51
    J.O. Fleming, Helminth therapy and multiple sclerosis, International Journal for Parasitology, 2013, 43, 3-4, 259

    CrossRef

  52. 52
    S. Montgomery, J. Hillert, S. Bahmanyar, Hospital admission due to infections in multiple sclerosis patients, European Journal of Neurology, 2013, 20, 8
  53. 53
    Giulio Podda, Mukanthu Nyirenda, James Crooks, Bruno Gran, Innate Immune Responses in the CNS: Role of Toll-Like Receptors, Mechanisms, and Therapeutic Opportunities in Multiple Sclerosis, Journal of Neuroimmune Pharmacology, 2013, 8, 4, 791

    CrossRef

  54. 54
    V. Ajdacic-Gross, A. Tschopp, M. Schmid, M. Bopp, F. Gutzwiller, Missed epidemics and missing links: international birth cohort trends in multiple sclerosis, European Journal of Neurology, 2013, 20, 3
  55. 55
    Christopher H. Hawkes, Multiple sclerosis genetics is dead, Multiple Sclerosis and Related Disorders, 2013, 2, 3, 156

    CrossRef

  56. 56
    Rina Aharoni, New findings and old controversies in the research of multiple sclerosis and its model experimental autoimmune encephalomyelitis, Expert Review of Clinical Immunology, 2013, 9, 5, 423

    CrossRef

  57. 57
    Yichuan Xiao, Jin Jin, Mikyoung Chang, Jae-Hoon Chang, Hongbo Hu, Xiaofei Zhou, George C Brittain, Christine Stansberg, Øivind Torkildsen, Xiaodong Wang, Robert Brink, Xuhong Cheng, Shao-Cong Sun, Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation, Nature Medicine, 2013, 19, 5, 595

    CrossRef

  58. 58
    Hartmut Wekerle, Kerstin Berer, Gurumoorthy Krishnamoorthy, Remote control—triggering of brain autoimmune disease in the gut, Current Opinion in Immunology, 2013, 25, 6, 683

    CrossRef

  59. 59
    Carole Lunny, Jennifer A Knopp-Sihota, Shawn N Fraser, Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case–control studies, BMC Neurology, 2013, 13, 1, 41

    CrossRef

  60. 60
    S. Anwar Jagessar, Zahra Fagrouch, Nicole Heijmans, Jan Bauer, Jon D. Laman, Luke Oh, Thi Migone, Ernst J. Verschoor, Bert A. ’t Hart, The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of γ-Herpesvirus Infected B Cells in the Marmoset EAE Model, Journal of Neuroimmune Pharmacology, 2013, 8, 3, 727

    CrossRef

  61. 61
    Silvia Messina, Francesco Patti, The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment, Expert Opinion on Drug Metabolism & Toxicology, 2013, 9, 10, 1349

    CrossRef

  62. 62
    Masami Tanaka, Topics of multiple sclerosis research presented at the 65th American Academy of Neurology Annual Meeting held at San Diego in 2013, Clinical and Experimental Neuroimmunology, 2013, 4, 1
  63. 63
    Barlas Büyüktimkin, Prakash Manikwar, Paul K. Kiptoo, Ahmed H. Badawi, John M. Stewart, Teruna J. Siahaan, Vaccinelike and Prophylactic Treatments of EAE with Novel I-Domain Antigen Conjugates (IDAC): Targeting Multiple Antigenic Peptides to APC, Molecular Pharmaceutics, 2013, 10, 1, 297

    CrossRef

  64. 64
    Miriam Mecha, Francisco J. Carrillo-Salinas, Leyre Mestre, Ana Feliú, Carmen Guaza, Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler's virus, Progress in Neurobiology, 2013, 101-102, 46

    CrossRef

  65. 65
    Li Zhou, Monica Miranda-Saksena, Nitin K Saksena, Viruses and neurodegeneration, Virology Journal, 2013, 10, 1, 172

    CrossRef

  66. 66
    Sarah Hewer, Robyn Lucas, Ingrid van der Mei, Bruce V. Taylor, Vitamin D and multiple sclerosis, Journal of Clinical Neuroscience, 2013, 20, 5, 634

    CrossRef

  67. 67
    Noel G Carlson, John W Rose, Vitamin D as a clinical biomarker in multiple sclerosis, Expert Opinion on Medical Diagnostics, 2013, 7, 3, 231

    CrossRef

  68. 68
    Marian Simka, What Could Be a Primary Cause of Multiple Sclerosis: Is It an Autoimmunity Triggered by Chronic Protozoan Infection?, Journal of Neuroparasitology, 2013, 4, 1

    CrossRef

  69. 69
    José M Valdueza, Florian Doepp, Stephan J Schreiber, Bob W van Oosten, Klaus Schmierer, Friedemann Paul, Mike P Wattjes, What went wrong? The flawed concept of cerebrospinal venous insufficiency, Journal of Cerebral Blood Flow & Metabolism, 2013, 33, 5, 657

    CrossRef

  70. 70
    Brenda L. Banwell, Pediatric Neurology, 2013,

    CrossRef

  71. 71
    Julia Pakpoor, Sreeram V Ramagopalan, Personalized Management of Multiple Sclerosis, 2013,

    CrossRef

  72. 72
    Sarah Lawrie, Amit Bar-Or, B cells set trends: Lessons from multiple sclerosis, Clinical and Experimental Neuroimmunology, 2012, 3, 3
  73. 73
    M. Pugliatti, I. Casetta, J. Drulovic, E. Granieri, T. Holmøy, M. T. Kampman, A.-M. Landtblom, K. Lauer, K.-M. Myhr, M. Parpinel, T. Pekmezovic, T. Riise, B. Zhu, C. Wolfson, A questionnaire for multinational case–control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q), Acta Neurologica Scandinavica, 2012, 126,
  74. 74
    K. Claire Simon, Shanie Saghafian-Hedengren, Eva Sverremark-Ekström, Caroline Nilsson, Alberto Ascherio, Age at Epstein-Barr virus infection and Epstein-Barr virus nuclear antigen-1 antibodies in Swedish children, Multiple Sclerosis and Related Disorders, 2012, 1, 3, 136

    CrossRef

  75. 75
    Roberta Rizzo, Valentina Gentili, Ilaria Casetta, Elisabetta Caselli, Riccardo De Gennaro, Enrico Granieri, Enzo Cassai, Dario Di Luca, Antonella Rotola, Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression, Journal of Neuroimmunology, 2012, 251, 1-2, 55

    CrossRef

  76. 76
    Richard M Ransohoff, Animal models of multiple sclerosis: the good, the bad and the bottom line, Nature Neuroscience, 2012, 15, 8, 1074

    CrossRef

  77. 77
    Mary A.M. Rogers, Deborah A. Levine, Neil Blumberg, Gwenith G. Fisher, Mohammed Kabeto, Kenneth M. Langa, Antigenic challenge in the etiology of autoimmune disease in women, Journal of Autoimmunity, 2012, 38, 2-3, J97

    CrossRef

  78. 78
    Vladeta Ajdacic-Gross, Margareta Schmid, Alois Tschopp, Felix Gutzwiller, Birth Cohort Effects in Neurological Diseases: Amyotrophic Lateral Sclerosis, Parkinson’s Disease and Multiple Sclerosis, Neuroepidemiology, 2012, 38, 1, 56

    CrossRef

  79. 79
    Michael P. Pender, CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis, Autoimmune Diseases, 2012, 2012, 1

    CrossRef

  80. 80
    Fatih Kantarci, Sait Albayram, Nuri Onat Demirci, Asim Esenkaya, Derya Uluduz, Omer Uysal, Sabahattin Saip, Aksel Siva, Chronic cerebrospinal venous insufficiency: does ultrasound really distinguish multiple sclerosis subjects from healthy controls?, European Radiology, 2012, 22, 5, 970

    CrossRef

  81. 81
    Manav Malhotra, Pankaj Ghai, Balasubramanian Narasimhan, Aakash Deep, Dalfampridine: Review on its recent development for symptomatic improvement in patients with multiple sclerosis, Arabian Journal of Chemistry, 2012,

    CrossRef

  82. 82
    Marcus W. Koch, Luanne M. Metz, Olga Kovalchuk, Epigenetic changes in patients with multiple sclerosis, Nature Reviews Neurology, 2012, 9, 1, 35

    CrossRef

  83. 83
    E Sundqvist, P Sundström, M Lindén, A K Hedström, F Aloisi, J Hillert, I Kockum, L Alfredsson, T Olsson, Epstein-Barr virus and multiple sclerosis: interaction with HLA, Genes and Immunity, 2012, 13, 1, 14

    CrossRef

  84. 84
    Meav-Lang J. Lay, Robyn M. Lucas, Cheryl Toi, Mala Ratnamohan, Anne-Louise Ponsonby, Dominic E. Dwyer, Epstein-Barr Virus Genotypes and Strains in Central Nervous System Demyelinating Disease and Epstein-Barr Virus-Related Illnesses in Australia, Intervirology, 2012, 55, 5, 372

    CrossRef

  85. 85
    Ranjan Dutta, Bruce D. Trapp, Gene expression profiling in multiple sclerosis brain, Neurobiology of Disease, 2012, 45, 1, 108

    CrossRef

  86. 86
    Jun-ichi Kira, Genetic and environmental backgrounds responsible for the changes in the phenotype of MS in Japanese subjects, Multiple Sclerosis and Related Disorders, 2012, 1, 4, 188

    CrossRef

  87. 87
    Kenneth P Johnson, Glatiramer acetate for treatment of relapsing–remitting multiple sclerosis, Expert Review of Neurotherapeutics, 2012, 12, 4, 371

    CrossRef

  88. 88
    Babak Jalilian, Halldór Einarsson, Thomas Vorup-Jensen, Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System?, International Journal of Molecular Sciences, 2012, 13, 12, 14579

    CrossRef

  89. 89
    Jason G. Weinger, Brian M. Weist, Warren C. Plaisted, Suzi M. Klaus, Craig M. Walsh, Thomas E. Lane, MHC Mismatch Results in Neural Progenitor Cell Rejection Following Spinal Cord Transplantation in a Model of Viral-Induced Demyelination, STEM CELLS, 2012, 30, 11
  90. 90
    J. G. McLeod, S. R. Hammond, J. F. Kurtzke, Migration and multiple sclerosis in United Kingdom and Ireland immigrants to Australia: a reassessment. II. Characteristics of early (pre-1947) compared to later migrants, Journal of Neurology, 2012, 259, 4, 684

    CrossRef

  91. 91
    C. H. Hawkes, S. Chawda, S. Derakshani, N. Muhammed, E. Visentin, D. Boniface, MRI and visual-evoked potentials in partners of multiple sclerosis patients, Acta Neurologica Scandinavica, 2012, 125, 6
  92. 92
    Alyssa Nylander, David A. Hafler, Multiple sclerosis, Journal of Clinical Investigation, 2012, 122, 4, 1180

    CrossRef

  93. 93
    Daniel Ontaneda, Megan Hyland, Jeffrey A. Cohen, Multiple Sclerosis: New Insights in Pathogenesis and Novel Therapeutics, Annual Review of Medicine, 2012, 63, 1, 389

    CrossRef

  94. 94
    Lucia M. Whitman, Caroline A. Blanc, Chris S. Schaumburg, David H. Rowitch, Thomas E. Lane, Olig1 function is required for remyelination potential of transplanted neural progenitor cells in a model of viral-induced demyelination, Experimental Neurology, 2012, 235, 1, 380

    CrossRef

  95. 95
    Hye-Ri Kang, Hye-Jeong Cho, Sungbum Kim, In Ho Song, Tae Sup Lee, Seungmin Hwang, Ren Sun, Moon Jung Song, Persistent infection of a gammaherpesvirus in the central nervous system, Virology, 2012, 423, 1, 23

    CrossRef

  96. 96
    Felipe von Glehn, Leonilda M Santos, Konstantin E Balashov, Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis, Immunotherapy, 2012, 4, 10, 1053

    CrossRef

  97. 97
    Rajneesh Srivastava, Muhammad Aslam, Sudhakar Reddy Kalluri, Lucas Schirmer, Dorothea Buck, Björn Tackenberg, Veit Rothhammer, Andrew Chan, Ralf Gold, Achim Berthele, Jeffrey L. Bennett, Thomas Korn, Bernhard Hemmer, Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis, New England Journal of Medicine, 2012, 367, 2, 115

    CrossRef

  98. 98
    S. Vukusic, Prévenir la sclérose en plaques : un objectif réaliste ?, Revue Neurologique, 2012, 168, 11, 836

    CrossRef

  99. 99
    J. Magarian Blander, Miriam B. Torchinsky, Laura Campisi, Revisiting the old link between infection and autoimmune disease with commensals and T helper 17 cells, Immunologic Research, 2012, 54, 1-3, 50

    CrossRef

  100. 100
    René M. Vigeveno, Oliver T. Wiebenga, Mike P. Wattjes, Jeroen J.G. Geurts, Frederik Barkhof, Shifting imaging targets in multiple sclerosis: From inflammation to neurodegeneration, Journal of Magnetic Resonance Imaging, 2012, 36, 1
  101. 101
    Vera Pravica, Dusan Popadic, Emina Savic, Milos Markovic, Jelena Drulovic, Marija Mostarica-Stojkovic, Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers, Immunologic Research, 2012, 52, 1-2, 42

    CrossRef

  102. 102
    Alberto Ascherio, Kassandra L. Munger, Jan D. Lünemann, The initiation and prevention of multiple sclerosis, Nature Reviews Neurology, 2012, 8, 11, 602

    CrossRef

  103. 103
    Serena Delbue, Silvia Carluccio, Pasquale Ferrante, The long and evolving relationship between viruses and multiple sclerosis, Future Virology, 2012, 7, 9, 871

    CrossRef

  104. 104
    Nicole Toepfner, Sabine Cepok, Verena Grummel, Bernhard Hemmer, The role of the Epstein–Barr Virus receptor CD21 in Multiple Sclerosis, Journal of Neuroimmunology, 2012, 242, 1-2, 47

    CrossRef

  105. 105
    Ajay Vikram Singh, Manish Khare, W. N. Gade, Paolo Zamboni, Theranostic Implications of Nanotechnology in Multiple Sclerosis: A Future Perspective, Autoimmune Diseases, 2012, 2012, 1

    CrossRef

  106. 106
    U.-C. Meier, G. Giovannoni, J. S. Tzartos, G. Khan, Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein–Barr virus entry to the central nervous system?, Clinical & Experimental Immunology, 2012, 167, 1
  107. 107
    Micha Loebermann, Alexander Winkelmann, Hans-Peter Hartung, Hartmut Hengel, Emil C. Reisinger, Uwe K. Zettl, Vaccination against infection in patients with multiple sclerosis, Nature Reviews Neurology, 2012, 8, 3, 143

    CrossRef

  108. 108
    Christopher Jankosky, Eric Deussing, Roger L. Gibson, Harry W. Haverkos, Viruses and vitamin D in the etiology of type 1 diabetes mellitus and multiple sclerosis, Virus Research, 2012, 163, 2, 424

    CrossRef

  109. 109
    Kelly C. Simon, Kassandra L. Munger, Alberto Ascherio, Vitamin D and multiple sclerosis, Current Opinion in Neurology, 2012, 25, 3, 246

    CrossRef

  110. 110
    G. Disanto, G. K. Sandve, A. J. Berlanga-Taylor, G. Ragnedda, J. M. Morahan, C. T. Watson, G. Giovannoni, G. C. Ebers, S. V. Ramagopalan, Vitamin D receptor binding, chromatin states and association with multiple sclerosis, Human Molecular Genetics, 2012, 21, 16, 3575

    CrossRef

  111. 111
    Katherine Buzzard, Simon Broadley, Helmut Butzkueven, What Do Effective Treatments for Multiple Sclerosis Tell Us about the Molecular Mechanisms Involved in Pathogenesis?, International Journal of Molecular Sciences, 2012, 13, 12, 12665

    CrossRef

  112. 112
    Lu Chen, Kevin S. Carbajal, Jason Weinger, Ronald Coleman, Thomas E. Lane, Human Stem Cell Manual, 2012,

    CrossRef

  113. 113
    Tanuja Chitnis, Samia J. Khoury, Neurology in Clinical Practice, 2012,

    CrossRef

  114. 114
    Pierre-Antoine Gourraud, Joseph P. McElroy, Stacy J. Caillier, Britt A. Johnson, Adam Santaniello, Stephen L. Hauser, Jorge R. Oksenberg, Aggregation of multiple sclerosis genetic risk variants in multiple and single case families, Annals of Neurology, 2011, 69, 1
  115. 115
    Hao Wang, Robert H. Yolken, Pieter J. Hoekstra, Huibert Burger, Hans C. Klein, Antibodies to infectious agents and the positive symptom dimension of subclinical psychosis: The TRAILS study, Schizophrenia Research, 2011, 129, 1, 47

    CrossRef

  116. 116
    A. Ghezzi, G. Comi, A. Federico, Chronic cerebro-spinal venous insufficiency (CCSVI) and multiple sclerosis, Neurological Sciences, 2011, 32, 1, 17

    CrossRef

  117. 117
    Stefano Bastianello, Alfredo Romani, Gisela Viselner, Enrico Tibaldi, Elisabetta Giugni, Marta Altieri, Pietro Cecconi, Laura Mendozzi, Massimiliano Farina, Donatella Mariani, Antonio Galassi, Claudio Quattrini, Marcello Mancini, Vincenzo Bresciamorra, Angela Lagace, Sandy McDonald, Giorgio Bono, Roberto Bergamaschi, Chronic cerebrospinal venous insufficiency in multiple sclerosis: clinical correlates from a multicentre study, BMC Neurology, 2011, 11, 1, 132

    CrossRef

  118. 118
    Robert Zivadinov, Murali Ramanathan, Kresimir Dolic, Karen Marr, Yuval Karmon, Adnan H Siddiqui, Ralph HB Benedict, Bianca Weinstock-Guttman, Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectives, Expert Review of Neurotherapeutics, 2011, 11, 9, 1277

    CrossRef

  119. 119
    Kerstin Berer, Marsilius Mues, Michail Koutrolos, Zakeya Al Rasbi, Marina Boziki, Caroline Johner, Hartmut Wekerle, Gurumoorthy Krishnamoorthy, Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination, Nature, 2011, 479, 7374, 538

    CrossRef

  120. 120
    G. K. Nikolopoulos, A. Masgala, C. Tsiara, O. K. Limitsiou, A. C. Karnaouri, N. L. Dimou, P. G. Bagos, Cytokine gene polymorphisms in multiple sclerosis: a meta-analysis of 45 studies including 7379 cases and 8131 controls, European Journal of Neurology, 2011, 18, 7
  121. 121
    Changning Wang, Chunying Wu, Junqing Zhu, Robert H. Miller, Yanming Wang, Design, Synthesis, and Evaluation of Coumarin-Based Molecular Probes for Imaging of Myelination, Journal of Medicinal Chemistry, 2011, 54, 7, 2331

    CrossRef

  122. 122
    Gary P. Siskin, Ziv J Haskal, Gordon McLennan, Michael D. Dake, E. Mark Haacke, Sandy McDonald, Walter Royal, Suresh Vedantham, David Hubbard, Salvatore J. Sclafani, R. Torrance Andrews, Heidi Sauder, Development of a Research Agenda for Evaluation of Interventional Therapies for Chronic Cerebrospinal Venous Insufficiency: Proceedings from a Multidisciplinary Research Consensus Panel, Journal of Vascular and Interventional Radiology, 2011, 22, 5, 587

    CrossRef

  123. 123
    Kassandra L. Munger, Tanuja Chitnis, A. Lindsay Frazier, Edward Giovannucci, Donna Spiegelman, Alberto Ascherio, Dietary intake of vitamin D during adolescence and risk of multiple sclerosis, Journal of Neurology, 2011, 258, 3, 479

    CrossRef

  124. 124
    K. C. Simon, X. Yang, K. L. Munger, A. Ascherio, EBNA1 and LMP1 variants in multiple sclerosis cases and controls, Acta Neurologica Scandinavica, 2011, 124, 1
  125. 125
    Dean M. Wingerchuk, Environmental Factors in Multiple Sclerosis: Epstein-Barr Virus, Vitamin D, and Cigarette Smoking, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2011, 78, 2
  126. 126
    Sreeram V. Ramagopalan, A. Dessa Sadovnick, Epidemiology of Multiple Sclerosis, Neurologic Clinics, 2011, 29, 2, 207

    CrossRef

  127. 127
    C. A. Young, Factors predisposing to the development of multiple sclerosis, QJM, 2011, 104, 5, 383

    CrossRef

  128. 128
    Mauricio F. Farez, Jorge Correale, Immunizations and risk of multiple sclerosis: systematic review and meta-analysis, Journal of Neurology, 2011, 258, 7, 1197

    CrossRef

  129. 129
    I.A.F. van der Mei, S. Simpson, J. Stankovich, B.V. Taylor, Individual and Joint Action of Environmental Factors and Risk of MS, Neurologic Clinics, 2011, 29, 2, 233

    CrossRef

  130. 130
    Jean-Luc Dreyer, Lentiviral Vector-Mediated Gene Transfer and RNA Silencing Technology in Neuronal Dysfunctions, Molecular Biotechnology, 2011, 47, 2, 169

    CrossRef

  131. 131
    O. W. Howell, C. A. Reeves, R. Nicholas, D. Carassiti, B. Radotra, S. M. Gentleman, B. Serafini, F. Aloisi, F. Roncaroli, R. Magliozzi, R. Reynolds, Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis, Brain, 2011, 134, 9, 2755

    CrossRef

  132. 132
    Joanne H Wang, Derek Pappas, Philip L De Jager, Daniel Pelletier, Paul IW de Bakker, Ludwig Kappos, Chris H Polman, Lori B Chibnik, David A Hafler, Paul M Matthews, Stephen L Hauser, Sergio E Baranzini, Jorge R Oksenberg, Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data, Genome Medicine, 2011, 3, 1, 3

    CrossRef

  133. 133
    A. Vatne, Å. Mygland, U. Ljøstad, Multiple sclerosis in Vest-Agder county, Norway, Acta Neurologica Scandinavica, 2011, 123, 6
  134. 134
    Bernd Krone, John M. Grange, Multiple Sclerosis: Are Protective Immune Mechanisms Compromised by a Complex Infectious Background?, Autoimmune Diseases, 2011, 2011, 1

    CrossRef

  135. 135
    Israel Steiner, On human disease and animal models, Annals of Neurology, 2011, 70, 3
  136. 136
    Jozélio Freire de Carvalho, Rosa Maria Rodrigues Pereira, Yehuda Shoenfeld, Pearls in autoimmunity, Autoimmunity Highlights, 2011, 2, 1, 1

    CrossRef

  137. 137
    Y. K. Lee, J. S. Menezes, Y. Umesaki, S. K. Mazmanian, Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis, Proceedings of the National Academy of Sciences, 2011, 108, Supplement_1, 4615

    CrossRef

  138. 138
    Subramaniam Sriram, Role of glial cells in innate immunity and their role in CNS demyelination, Journal of Neuroimmunology, 2011, 239, 1-2, 13

    CrossRef

  139. 139
    Asta Juzeniene, Pål Brekke, Arne Dahlback, Stefan Andersson-Engels, Jörg Reichrath, Kristin Moan, Michael F Holick, William B Grant, Johan Moan, Solar radiation and human health, Reports on Progress in Physics, 2011, 74, 6, 066701

    CrossRef

  140. 140
    Tzu-Yun McDowell, Sania Amr, William J. Culpepper, Patricia Langenberg, Walter Royal, Christopher Bever, Douglas D. Bradham, Sun Exposure, Vitamin D Intake and Progression to Disability among Veterans with Progressive Multiple Sclerosis, Neuroepidemiology, 2011, 37, 1, 52

    CrossRef

  141. 141
    Anne-Louise Ponsonby, Ann Maree Hughes, Robyn Marjorie Lucas, The ‘hygiene hypothesis’ and the development of multiple sclerosis, Neurodegenerative Disease Management, 2011, 1, 4, 285

    CrossRef

  142. 142
    Aleksandar Denic, Aaron J. Johnson, Allan J. Bieber, Arthur E. Warrington, Moses Rodriguez, Istvan Pirko, The relevance of animal models in multiple sclerosis research, Pathophysiology, 2011, 18, 1, 21

    CrossRef

  143. 143
    G. Füst, The role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders — Similarities and differences, European Journal of Microbiology and Immunology, 2011, 1, 4, 267

    CrossRef

  144. 144
    Brenda Banwell, Amit Bar-Or, Gavin Giovannoni, Russell C. Dale, Marc Tardieu, Therapies for multiple sclerosis: considerations in the pediatric patient, Nature Reviews Neurology, 2011, 7, 2, 109

    CrossRef

  145. 145
    N. Couturier, F. Bucciarelli, R. N. Nurtdinov, M. Debouverie, C. Lebrun-Frenay, G. Defer, T. Moreau, C. Confavreux, S. Vukusic, I. Cournu-Rebeix, R. H. Goertsches, U. K. Zettl, M. Comabella, X. Montalban, P. Rieckmann, F. Weber, B. Muller-Myhsok, G. Edan, B. Fontaine, L. T. Mars, A. Saoudi, J. R. Oksenberg, M. Clanet, R. S. Liblau, D. Brassat, Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility, Brain, 2011, 134, 3, 693

    CrossRef

  146. 146
    Amir-Hadi Maghzi, Monica Marta, Isabel Bosca, Masoud Etemadifar, Ruth Dobson, Cosimo Maggiore, Gavin Giovannoni, Ute-Christiane Meier, Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?, Pathophysiology, 2011, 18, 1, 13

    CrossRef

  147. 147
    Kristina Kakalacheva, Christian Münz, Jan D. Lünemann, Viral triggers of multiple sclerosis, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011, 1812, 2, 132

    CrossRef

  148. 148
    Giulio Disanto, Ute Meier, Gavin Giovannoni, Sreeram V Ramagopalan, Vitamin D: a link between Epstein–Barr virus and multiple sclerosis development?, Expert Review of Neurotherapeutics, 2011, 11, 9, 1221

    CrossRef

  149. 149
    J.-P. Neau, M.-S. Artaud-Uriot, V. Lhomme, J.-Y. Bounaud, F. Lebras, L. Boissonnot, N. Moinot, J. Ciron, D. Larrieu, S. Mathis, G. Godeneche, P. Ingrand, Vitamine D et sclérose en plaques. Étude prospective d’une cohorte de patients de la région Poitou-Charentes, Revue Neurologique, 2011, 167, 4, 317

    CrossRef

  150. 150
    Charles Pierrot-Deseilligny, Jean-Claude Souberbielle, Widespread vitamin D insufficiency: A new challenge for primary prevention, with particular reference to multiple sclerosis, La Presse Médicale, 2011, 40, 4, 349

    CrossRef

  151. 151
    Kelly Claire Simon, Kassandra L. Munger, Alberto Ascherio, XVI European Charcot Foundation lecture: Nutrition and environment, can MS be prevented?, Journal of the Neurological Sciences, 2011, 311, 1-2, 1

    CrossRef

  152. 152
    A Guide to Evidence-based Integrative and Complementary Medicine, 2011,

    CrossRef

  153. 153
    Amir-Hadi Maghzi, Monica Marta, Isabel Bosca, Mohammad-Reza Savoj, Masoud Etemadifar, Gavin Giovannoni, Ute-Christiane Meier, Neuroinflammation, 2011,

    CrossRef

  154. 154
    A. Ascherio, K. L. Munger, 99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Epstein–Barr virus and multiple sclerosis: epidemiological evidence, Clinical & Experimental Immunology, 2010, 160, 1
  155. 155
    Dennis K. Kinney, Kathryn Hintz, Erika M. Shearer, Daniel H. Barch, Catherine Riffin, Katherine Whitley, Robert Butler, A unifying hypothesis of schizophrenia: Abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction, Medical Hypotheses, 2010, 74, 3, 555

    CrossRef

  156. 156
    William B. Grant, Gerry K. Schwalfenberg, Stephen J. Genuis, Susan J. Whiting, An estimate of the economic burden and premature deaths due to vitamin D deficiency in Canada, Molecular Nutrition & Food Research, 2010, 54, 8
  157. 157
    Emanuele Tirotta, Kevin S. Carbajal, Chris S. Schaumburg, Lucia Whitman, Thomas E. Lane, Cell replacement therapies to promote remyelination in a viral model of demyelination, Journal of Neuroimmunology, 2010, 224, 1-2, 101

    CrossRef

  158. 158
    Omar Khan, Massimo Filippi, Mark S. Freedman, Frederik Barkhof, Paula Dore-Duffy, Hans Lassmann, Bruce Trapp, Amit Bar-Or, Imad Zak, Marilyn J. Siegel, Robert Lisak, Chronic cerebrospinal venous insufficiency and multiple sclerosis, Annals of Neurology, 2010, 67, 3
  159. 159
    F. Aloisi, B. Serafini, R. Magliozzi, O. W. Howell, R. Reynolds, Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look, Brain, 2010, 133, 12, e157

    CrossRef

  160. 160
    Samantha Jilek, Hans H Hirsch, Giuseppe Pantaleo, Renaud A Du Pasquier, Discrepant findings in immune responses to JC virus in patients receiving natalizumab – Authors' reply, The Lancet Neurology, 2010, 9, 6, 566

    CrossRef

  161. 161
    Jan D. Lünemann, Mar Tintoré, Brady Messmer, Till Strowig, Álex Rovira, Héctor Perkal, Estrella Caballero, Christian Münz, Xavier Montalban, Manuel Comabella, Elevated Epstein–Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis, Annals of Neurology, 2010, 67, 2
  162. 162
    Adam E. Handel, Gavin Giovannoni, George C. Ebers, Sreeram V. Ramagopalan, Environmental factors and their timing in adult-onset multiple sclerosis, Nature Reviews Neurology, 2010, 6, 3, 156

    CrossRef

  163. 163
    Klaus Lauer, Environmental risk factors in multiple sclerosis, Expert Review of Neurotherapeutics, 2010, 10, 3, 421

    CrossRef

  164. 164
    L. A. N. Peferoen, F. Lamers, L. N. R. Lodder, W. H. Gerritsen, I. Huitinga, J. Melief, G. Giovannoni, U. Meier, R. Q. Hintzen, G. M. G. M. Verjans, G. P. van Nierop, W. Vos, R. M. B. Peferoen-Baert, J. M. Middeldorp, P. van der Valk, S. Amor, Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis, Brain, 2010, 133, 5, e137

    CrossRef

  165. 165
    Barbara Serafini, Martina Severa, Sandra Columba-Cabezas, Barbara Rosicarelli, Caterina Veroni, Giuseppe Chiappetta, Roberta Magliozzi, Richard Reynolds, Eliana Marina Coccia, Francesca Aloisi, Epstein-Barr Virus Latent Infection and BAFF Expression in B Cells in the Multiple Sclerosis Brain, Journal of Neuropathology and Experimental Neurology, 2010, 69, 7, 677

    CrossRef

  166. 166
    Alberto Ascherio, Kassandra L. Munger, Epstein–Barr Virus Infection and Multiple Sclerosis: A Review, Journal of Neuroimmune Pharmacology, 2010, 5, 3, 271

    CrossRef

  167. 167
    J. W. Lindsey, L. M. Hatfield, T. Vu, Epstein–Barr virus neutralizing and early antigen antibodies in multiple sclerosis, European Journal of Neurology, 2010, 17, 10
  168. 168
    Emilie Jaquiéry, Samantha Jilek, Myriam Schluep, Pascal Meylan, Andreas Lysandropoulos, Giuseppe Pantaleo, Renaud A. Du Pasquier, Intrathecal immune responses to EBV in early MS, European Journal of Immunology, 2010, 40, 3
  169. 169
    C. Pierrot-Deseilligny, J.-C. Souberbielle, Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?, Brain, 2010, 133, 7, 1869

    CrossRef

  170. 170
    K. S. Carbajal, C. Schaumburg, R. Strieter, J. Kane, T. E. Lane, Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis, Proceedings of the National Academy of Sciences, 2010, 107, 24, 11068

    CrossRef

  171. 171
    Michel Brahic, Multiple sclerosis and viruses, Annals of Neurology, 2010, 68, 1
  172. 172
    Jorge R. Oksenberg, Sergio E. Baranzini, Multiple sclerosis genetics—is the glass half full, or half empty?, Nature Reviews Neurology, 2010, 6, 8, 429

    CrossRef

  173. 173
    Ron Milo, Esther Kahana, Multiple sclerosis: Geoepidemiology, genetics and the environment, Autoimmunity Reviews, 2010, 9, 5, A387

    CrossRef

  174. 174
    Sreeram V Ramagopalan, Ruth Dobson, Ute C Meier, Gavin Giovannoni, Multiple sclerosis: risk factors, prodromes, and potential causal pathways, The Lancet Neurology, 2010, 9, 7, 727

    CrossRef

  175. 175
    J.E. Martínez-Rodríguez, A. Saez-Borderías, E. Munteis, N. Romo, J. Roquer, M. López-Botet, Natural killer receptors distribution in multiple sclerosis: Relation to clinical course and interferon-beta therapy, Clinical Immunology, 2010, 137, 1, 41

    CrossRef

  176. 176
    Naghmeh Jafari, Gijsbert P. van Nierop, Georges M.G.M. Verjans, Albert D.M.E. Osterhaus, Jaap M. Middeldorp, Rogier Q. Hintzen, No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis, Journal of Clinical Virology, 2010, 49, 1, 26

    CrossRef

  177. 177
    Laura Bergamaschi, Maria Ban, Maurizio A. Leone, Stephen J. Sawcer, Sandra D'Alfonso, No evidence of association of the rare nsSNP rs35667974 in IFIH1 with multiple sclerosis, Journal of Neuroimmunology, 2010, 221, 1-2, 112

    CrossRef

  178. 178
    Jane C Elliott, Robyn M Lucas, Mark S Clements, Hilary J Bambrick, Population density determines the direction of the association between ambient ultraviolet radiation and type 1 diabetes incidence, Pediatric Diabetes, 2010, 11, 6
  179. 179
    O. Santiago, J. Gutierrez, A. Sorlozano, J. Dios Luna, E. Villegas, O. Fernandez, Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production, European Journal of Clinical Microbiology & Infectious Diseases, 2010, 29, 7, 857

    CrossRef

  180. 180
    Hong-Liang Zhang, Jiang Wu, Role of vitamin D in immune responses and autoimmune diseases, with emphasis on its role in multiple sclerosis, Neuroscience Bulletin, 2010, 26, 6, 445

    CrossRef

  181. 181
    Anne Lise K. Hestvik, The Double-Edged Sword of Autoimmunity: Lessons from Multiple Sclerosis, Toxins, 2010, 2, 4, 856

    CrossRef

  182. 182
    Trygve Holmøy, Frode Vartdal, Anne Lise Hestvik, Ludvig Munthe, Bjarne Bogen, The idiotype connection: linking infection and multiple sclerosis, Trends in Immunology, 2010, 31, 2, 56

    CrossRef

  183. 183
    Jochen C. Ulzheimer, Sven G. Meuth, Stefan Bittner, Christoph Kleinschnitz, Bernd C. Kieseier, Heinz Wiendl, Therapeutic Approaches to Multiple Sclerosis, BioDrugs, 2010, 24, 4, 249

    CrossRef

  184. 184
    Richard M Ransohoff, Turning over the Chance card on MS susceptibility, Nature Immunology, 2010, 11, 7, 570

    CrossRef

  185. 185
    Alberto Ascherio, Kassandra L Munger, K Claire Simon, Vitamin D and multiple sclerosis, The Lancet Neurology, 2010, 9, 6, 599

    CrossRef

  186. 186
    Gilles Defer, Bruno Brochet, Jean Pelletier, Neuropsychologie de la sclérose en plaques, 2010,

    CrossRef

  187. 187
    Alberto Ascherio, Kassandra L. Munger, MULTIPLE SCLEROSIS 3, 2010,

    CrossRef

  188. 188
    Gregory P. Owens, Jeffrey L. Bennett, Hans Lassmann, Kevin C. O'Connor, Alanna M. Ritchie, Andrew Shearer, Chiwah Lam, Xiaoli Yu, Marius Birlea, Cecily DuPree, R. Anthony Williamson, David A. Hafler, Mark P. Burgoon, Don Gilden, Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid, Annals of Neurology, 2009, 65, 6
  189. 189
    T. Menge, H.-C. Büdingen, M.C. Dalakas, B.C. Kieseier, H.-P. Hartung, B-Zell-gerichtete Multiple-Sklerose-Therapie, Der Nervenarzt, 2009, 80, 2, 190

    CrossRef

  190. 190
    Charles Pierrot-Deseilligny, Clinical implications of a possible role of vitamin D in multiple sclerosis, Journal of Neurology, 2009, 256, 9, 1468

    CrossRef

  191. 191
    Y. Mikaeloff, G. Caridade, S. Suissa, M. Tardieu, Clinically Observed Chickenpox and the Risk of Childhood-onset Multiple Sclerosis, American Journal of Epidemiology, 2009, 169, 10, 1260

    CrossRef

  192. 192
    Violaine K. Harris, Saud A. Sadiq, Disease Biomarkers in Multiple Sclerosis, Molecular Diagnosis & Therapy, 2009, 13, 4, 225

    CrossRef

  193. 193
    S. N. Willis, C. Stadelmann, S. J. Rodig, T. Caron, S. Gattenloehner, S. S. Mallozzi, J. E. Roughan, S. E. Almendinger, M. M. Blewett, W. Bruck, D. A. Hafler, K. C. O'Connor, Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain, Brain, 2009, 132, 12, 3318

    CrossRef

  194. 194
    Marco Salvetti, Gavin Giovannoni, Francesca Aloisi, Epstein–Barr virus and multiple sclerosis, Current Opinion in Neurology, 2009, 22, 3, 201

    CrossRef

  195. 195
    William B. Grant, Heide S. Cross, Cedric F. Garland, Edward D. Gorham, Johan Moan, Meinrad Peterlik, Alina C. Porojnicu, Jörg Reichrath, Armin Zittermann, Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe, Progress in Biophysics and Molecular Biology, 2009, 99, 2-3, 104

    CrossRef

  196. 196
    Robert Zivadinov, Bianca Weinstock-Guttman, Marino Zorzon, Laura Uxa, Maurizia Serafin, Antonio Bosco, Alessio Bratina, Cosimo Maggiore, Attilio Grop, Maria Antonietta Tommasi, Bhooma Srinivasaraghavan, Murali Ramanathan, Gene–environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis, Journal of Neuroimmunology, 2009, 209, 1-2, 123

    CrossRef

  197. 197
    R.L. Zuvich, J.L. McCauley, M.A. Pericak-Vance, J.L. Haines, Genetics and pathogenesis of multiple sclerosis, Seminars in Immunology, 2009, 21, 6, 328

    CrossRef

  198. 198
    Anne Lise Karlsgot Hestvik, Gjertrud Skorstad, Frode Vartdal, Trygve Holmøy, Idiotope-specific CD4+ T cells induce apoptosis of human oligodendrocytes, Journal of Autoimmunity, 2009, 32, 2, 125

    CrossRef

  199. 199
    Bernd Krone, Frank Oeffner, John M. Grange, Is the risk of multiple sclerosis related to the ‘biography’ of the immune system?, Journal of Neurology, 2009, 256, 7, 1052

    CrossRef

  200. 200
    Laurent Magy, La sclérose en plaques, Actualités Pharmaceutiques Hospitalières, 2009, 5, 19, 14

    CrossRef

  201. 201
    Dena J. Fischer, Joel B. Epstein, Gary Klasser, Multiple sclerosis: an update for oral health care providers, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2009, 108, 3, 318

    CrossRef

  202. 202
    Giuseppe Mameli, Luciana Poddighe, Vito Astone, Giuseppe Delogu, Giannina Arru, Stefano Sotgiu, Caterina Serra, Antonina Dolei, Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis, Journal of Virological Methods, 2009, 161, 1, 98

    CrossRef

  203. 203
    Manuel A. Friese, Lars Fugger, Pathogenic CD8+ T cells in multiple sclerosis, Annals of Neurology, 2009, 66, 2
  204. 204
    Hannah Gardener, Kassandra L. Munger, Tanuja Chitnis, Karin B. Michels, Donna Spiegelman, Alberto Ascherio, Prenatal and Perinatal Factors and Risk of Multiple Sclerosis, Epidemiology, 2009, 20, 4, 611

    CrossRef

  205. 205
    Michael P. Pender, Preventing and curing multiple sclerosis by controlling Epstein–Barr virus infection, Autoimmunity Reviews, 2009, 8, 7, 563

    CrossRef

  206. 206
    Greg P. Blaney, Paul J. Albert, Amy D. Proal, Vitamin D Metabolites as Clinical Markers in Autoimmune and Chronic Disease, Annals of the New York Academy of Sciences, 2009, 1173, 1
  207. 207
    Colleen E. Hayes, E. Donald Acheson, A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10, Medical Hypotheses, 2008, 71, 1, 85

    CrossRef

  208. You have free access to this content208
    Brenda Banwell, Amit Bar-Or, Roy Cheung, Julia Kennedy, Lauren B. Krupp, Dorothy J. Becker, Hans-Michael Dosch, Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes, Annals of Neurology, 2008, 63, 1
  209. 209
    Donald R. Staines, Are multiple sclerosis and amyotrophic lateral sclerosis autoimmune disorders of endogenous vasoactive neuropeptides?, Medical Hypotheses, 2008, 70, 2, 413

    CrossRef

  210. 210
    Tamara Vyshkina, Bernadette Kalman, Autoantibodies and neurodegeneration in multiple sclerosis, Laboratory Investigation, 2008, 88, 8, 796

    CrossRef

  211. 211
    Diego Franciotta, Marco Salvetti, Francesco Lolli, Barbara Serafini, Francesca Aloisi, B cells and multiple sclerosis, The Lancet Neurology, 2008, 7, 9, 852

    CrossRef

  212. 212
    Carlo Contini, Silva Seraceni, Massimiliano Castellazzi, Enrico Granieri, Enrico Fainardi, Chlamydophila pneumoniae DNA and mRNA transcript levels in peripheral blood mononuclear cells and cerebrospinal fluid of patients with multiple sclerosis, Neuroscience Research, 2008, 62, 1, 58

    CrossRef

  213. 213
    Mary Norval, Gregory M. Woods, Comment on “Hypothesis—Ultraviolet-B Irradiance and Vitamin D Reduce the Risk of Viral Infections and thus their Sequelae, Including Autoimmune Diseases and some Cancers” by W.B. Grant, Photochem. Photobiol. (2007), Photochemistry and Photobiology, 2008, 84, 3
  214. 214
    John A. Lincoln, Karolina Hankiewicz, Stuart D. Cook, Could Epstein-Barr Virus or Canine Distemper Virus Cause Multiple Sclerosis?, Neurologic Clinics, 2008, 26, 3, 699

    CrossRef

  215. 215
    Til Menge, Martin S Weber, Bernhard Hemmer, Bernd C Kieseier, Hans-Christian von Büdingen, Clemens Warnke, Scott S Zamvil, Aaron Boster, Omar Khan, Hans-Peter Hartung, Olaf Stüve, Disease-Modifying Agents for Multiple Sclerosis, Drugs, 2008, 68, 17, 2445

    CrossRef

  216. 216
    George C Ebers, Environmental factors and multiple sclerosis, The Lancet Neurology, 2008, 7, 3, 268

    CrossRef

  217. 217
    J.R. Berger, Environmental Risk Factors for Multiple Sclerosis. Part I: The Role of Infection, Yearbook of Neurology and Neurosurgery, 2008, 2008, 170

    CrossRef

  218. 218
    M. Pugliatti, H. F. Harbo, T. Holmøy, M. T. Kampman, K.-M. Myhr, T. Riise, C. Wolfson, Environmental risk factors in multiple sclerosis, Acta Neurologica Scandinavica, 2008, 117,
  219. 219
    Alberto Ascherio, Epstein–Barr virus in the development of multiple sclerosis, Expert Review of Neurotherapeutics, 2008, 8, 3, 331

    CrossRef

  220. 220
    Ø. Torkildsen, H. Nyland, H. Myrmel, K.-M. Myhr, Epstein–Barr virus reactivation and multiple sclerosis, European Journal of Neurology, 2008, 15, 1
  221. 221
    William B. Grant, Hypothesis—Ultraviolet-B Irradiance and Vitamin D Reduce the Risk of Viral Infections and thus Their Sequelae, Including Autoimmune Diseases and some Cancers, Photochemistry and Photobiology, 2008, 84, 2
  222. 222
    Francesca Aloisi, Sandra Columba-Cabezas, Diego Franciotta, Barbara Rosicarelli, Roberta Magliozzi, Richard Reynolds, Elena Ambrosini, Eliana Coccia, Marco Salvetti, Barbara Serafini, Lymphoid chemokines in chronic neuroinflammation, Journal of Neuroimmunology, 2008, 198, 1-2, 106

    CrossRef

  223. 223
    Cristina Maria Costantino, Clare Baecher-Allan, David A. Hafler, Multiple Sclerosis and Regulatory T Cells, Journal of Clinical Immunology, 2008, 28, 6, 697

    CrossRef

  224. 224
    Trygve Holmøy, Anne Lise K Hestvik, Multiple sclerosis: immunopathogenesis and controversies in defining the cause, Current Opinion in Infectious Diseases, 2008, 21, 3, 271

    CrossRef

  225. 225
    K. Ruprecht, Multiple Sklerose und Epstein-Barr-Virus, Der Nervenarzt, 2008, 79, 4, 399

    CrossRef

  226. 226
    Gregor K. Wenning, Nadia Stefanova, Kurt A. Jellinger, Werner Poewe, Michael G. Schlossmacher, Multiple system atrophy: A primary oligodendrogliopathy, Annals of Neurology, 2008, 64, 3
  227. 227
    Hiroaki Yokote, Sachiko Miyake, J. Ludovic Croxford, Shinji Oki, Hidehiro Mizusawa, Takashi Yamamura, NKT Cell-Dependent Amelioration of a Mouse Model of Multiple Sclerosis by Altering Gut Flora, The American Journal of Pathology, 2008, 173, 6, 1714

    CrossRef

  228. 228
    S. Jilek, M. Schluep, P. Meylan, F. Vingerhoets, L. Guignard, A. Monney, J. Kleeberg, G. Le Goff, G. Pantaleo, R. A. Du Pasquier, Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis, Brain, 2008, 131, 7, 1712

    CrossRef

  229. 229
    Francisco J. Quintana, Mauricio F. Farez, Howard L. Weiner, Systems biology approaches for the study of multiple sclerosis, Journal of Cellular and Molecular Medicine, 2008, 12, 4
  230. 230
    Jorge R. Oksenberg, Sergio E. Baranzini, Stephen Sawcer, Stephen L. Hauser, The genetics of multiple sclerosis: SNPs to pathways to pathogenesis, Nature Reviews Genetics, 2008, 9, 7, 516

    CrossRef

  231. You have free access to this content231
    Margherita T Cantorna, Vitamin D and multiple sclerosis: an update, Nutrition Reviews, 2008, 66,
  232. 232
    Margitta T. Kampman, Magritt Brustad, Vitamin D: A Candidate for the Environmental Effect in Multiple Sclerosis – Observations from Norway, Neuroepidemiology, 2008, 30, 3, 140

    CrossRef

  233. 233
    M. Riverol, J. Sepulcre, M. Fernandez-Alonso, A. Uccelli, L. Brieva, M. Rubio, A. Rodriguez, B. Fernandez-Diez, P. Villoslada, Antibodies against Epstein–Barr virus and herpesvirus type 6 are associated with the early phases of Multiple Sclerosis, Journal of Neuroimmunology, 2007, 192, 1-2, 184

    CrossRef

  234. 234
    Ernest C. Borden, Ganes C. Sen, Gilles Uze, Robert H. Silverman, Richard M. Ransohoff, Graham R. Foster, George R. Stark, Interferons at age 50: past, current and future impact on biomedicine, Nature Reviews Drug Discovery, 2007, 6, 12, 975

    CrossRef

  235. 235
    Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study, New England Journal of Medicine, 2007, 357, 9, 851

    CrossRef

  236. 236
    Kassandra L Munger, Alberto Ascherio, Risk factors in the development of multiple sclerosis, Expert Review of Clinical Immunology, 2007, 3, 5, 739

    CrossRef

  237. 237
    Dana J. Serafin, Deborah M. Weisbrot, Alan B. Ettinger, Depression and Multiple Sclerosis,
  238. 238
    Philip L. De Jager, Epidemiology and Genetics,
  239. 239
    Sonya U. Steele, Ellen M. Mowry, Etiology,
  240. 240
    Florian P. Thomas, Multiple Sclerosis,
  241. 241
    DA Dyment, GC Ebers, Multiple Sclerosis (MS): Genetics, eLS,
  242. 242
    Esther J van Zuuren, Zbys Fedorowicz, Eugenio Pucci, Vanitha A Jagannath, Edward W Robak, Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients, The Cochrane Library,
  243. 243
    Esther J van Zuuren, Zbys Fedorowicz, Eugenio Pucci, Vanitha A Jagannath, Edward W Robak, Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients, The Cochrane Library,